View source version on businesswirecom  httpswwwbusinesswirecomnewshome20230316005693en Investor Contact Ian Estepan  6172744052 iestepansareptacom Media Contact Tracy Sorrentino  6173018566 tsorrentinosareptacom Source Sarepta Therapeutics Inc